House Joint Resolution 98, sponsored by Representative Fritts, urges the United States Congress to mandate that the Department of Veterans Affairs (VA) include COVID-19 treatments and anthrax vaccinations as qualifying conditions for care under the PACT Act. The resolution highlights concerns that many servicemembers have been unlawfully compelled to receive these treatments, which were administered under Emergency Use Authorization (EUA) rather than full FDA approval. It emphasizes the historical context of the government's treatment of servicemembers regarding experimental substances and the potential long-term health impacts of such actions.

Additionally, the resolution calls for a comprehensive investigation into the decision-making processes surrounding the administration of these treatments, including accountability for those involved. It stresses the importance of ensuring that servicemembers receive the care and benefits they deserve, particularly in light of the PACT Act's provisions for veterans exposed to toxic substances. The resolution aims to protect the welfare of servicemembers and ensure adherence to legal and ethical standards in their healthcare.